Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer ... Based Algorithm Based on Liquid Biosciences EMERGE Platform ...

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

In this video, Michael Cecchini, MD, discusses results of two clinical trials evaluating pamrevlumab in pancreatic cancer, which were presented at ASCO Gastrointestinal Cancers Symposium.

Mar. 18, 2025 — Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

Cancer researchers at Children's Medical Research Institute have discovered an "unexpected mechanism" that our cells use to avoid cancer.

NEW YORK – European regulators have cleared Anocca to begin a Phase I/II umbrella trial of its lead targeted T-cell receptor (TCR) therapy ANOC-001 and other pipeline candidates in certain advanced ...

Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health ...

AstraZeneca's pan-AKT kinase inhibitor for breast cancer, which has shown efficacy in patients with hormone receptor positive, HER2-negative advanced breast cancer – regardless of their PIK3CA ...

NEW YORK – The US Food and Drug Administration has granted Precision BioSciences permission to begin a Phase I trial of its in vivo gene-editing therapeutic candidate for chronic hepatitis B virus ...